Inside the World of Counterfeit Drugs

Part 3: Implications for the U.S. and the Drug Importation Debate – As the debate surrounding the possible ban on the repackaging of medicines in Europe simmers to a boil, here in the United States the potentially dangerous practice of ordering prescription medicines via the Internet is mushrooming. Enticed by the promise of cheaper drugs and convenience by buying online, patients are largely unaware of the risks that come with online pharmacies. These risks can range from receiving products with too much, too little or no active ingredients, to being exposed to counterfeit products, which in some rare cases have been found to contain rat poison, boric acid and even inkjet cartridges!

[...]

Inside the World of Counterfeit Drugs

Part 2: The European Repackaging Debate – Last week we witnessed the confusing practice of repackaging of prescription medicines within the European Union (EU) through the eyes of a fictitious Dutch patient picking up his blood pressure tablets at a city retail pharmacy. The patient’s experience is shared by millions of Europeans living in Germany, Great Britain, and Holland among other countries. Under current EU rules, medicines can be re-boxed or re-labeled after they leave the site of production, and tablets can be removed from their blisters and reconditioned. Counterfeiters can exploit this fact in order to sneak their fake goods past regulators. One of the prime sources of counterfeit medicines, which can enter the drug supply at the point of repackaging, is the Internet.

[...]

Inside the World of Counterfeit Drugs

Part 1: Your critical role in safe medicines — In recent blog entries, the Partnership for Safe Medicines’ (PSM) experts have warned consumers and pharmacists of the dangers that counterfeit drugs pose, recapped legislation surrounding these issues and highlighting incidents of counterfeit drugs from across the world. However, this month we have invited guest blogger Gregory Zec to share his thoughts on some current drug safety issues. This week, Gregory uses a fictional consumer’s experiences (which he based on real patients’ stories) to explore the confusion many patients encounter from when they receive repackaged, imported prescription drugs from a legitimate pharmacy.

[...]